Record Information
Version3.6
Creation Date2012-09-06 15:16:50 UTC
Update Date2013-02-09 00:32:12 UTC
HMDB IDHMDB14730
Secondary Accession NumbersNone
Metabolite Identification
Common NamePiperazine
DescriptionPiperazine is an organic compound that consists of a six-membered ring containing two opposing nitrogen atoms. Piperazine exists as small alkaline deliquescent crystals with a saline taste. Piperazine was introduced to medicine as a solvent for uric acid. When taken into the body the drug is partly oxidized and partly eliminated unchanged. Outside the body, piperazine has a remarkable power to dissolve uric acid and producing a soluble urate, but in clinical experience it has not proved equally successful. Piperazine was first introduced as an anthelmintic in 1953. A large number of piperazine compounds have anthelmintic action. Their mode of action is generally by paralysing parasites, which allows the host body to easily remove or expel the invading organism.
Structure
Thumb
Synonyms
  1. Diethylenediamine
  2. Diethyleneimine
  3. Fluphenazine dihydrochloride
  4. Hexahydropyrazine
  5. Piperazin
  6. Piperazin [Germany]
  7. Piperazine hexahydrate
  8. Piperazine hydrate
Chemical FormulaC4H10N2
Average Molecular Weight86.1356
Monoisotopic Molecular Weight86.08439833
IUPAC Namepiperazine
Traditional IUPAC Namepiperazine
CAS Registry Number110-85-0
SMILES
C1CNCCN1
InChI Identifier
InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
InChI KeyGLUUGHFHXGJENI-UHFFFAOYSA-N
Chemical Taxonomy
KingdomOrganic Compounds
Super ClassAliphatic Heteromonocyclic Compounds
ClassPiperazines
Sub ClassN/A
Other Descriptors
  • Aliphatic Heteromonocyclic Compounds
  • azacycloalkane(ChEBI)
  • piperazines(ChEBI)
  • saturated organic heteromonocyclic parent(ChEBI)
Substituents
  • Secondary Aliphatic Amine (Dialkylamine)
Direct ParentPiperazines
Ontology
StatusExpected and Not Quantified
Origin
  • Drug
Biofunction
  • Anthelmintics
  • Antinematodal Agents
Application
  • Pharmaceutical
Cellular locations
  • Membrane
Physical Properties
StateSolid
Experimental Properties
PropertyValueReference
Melting Point106 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility3.71e+02 g/LNot Available
LogP-0.8Not Available
Predicted Properties
PropertyValueSource
water solubility371 g/LALOGPS
logP-1.2ALOGPS
logP-0.73ChemAxon
logS0.63ALOGPS
pKa (strongest basic)9.56ChemAxon
physiological charge1ChemAxon
hydrogen acceptor count2ChemAxon
hydrogen donor count2ChemAxon
polar surface area24.06ChemAxon
rotatable bond count0ChemAxon
refractivity25.45ChemAxon
polarizability9.97ChemAxon
Spectra
SpectraNot Available
Biological Properties
Cellular Locations
  • Membrane
Biofluid Locations
  • Blood
  • Urine
Tissue LocationNot Available
PathwaysNot Available
Normal Concentrations
BiofluidStatusValueAgeSexConditionReference
BloodExpected but not QuantifiedNot ApplicableNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00592
  • Not Applicable
UrineExpected but not QuantifiedNot ApplicableNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00592
  • Not Applicable
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00592
DrugBank Metabolite IDNot Available
Phenol Explorer Compound IDNot Available
Phenol Explorer Metabolite IDNot Available
FoodDB IDFDB012189
KNApSAcK IDNot Available
Chemspider ID13835459
KEGG Compound IDC07973
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPiperazine
NuGOwiki LinkHMDB14730
Metagene LinkHMDB14730
METLIN IDNot Available
PubChem Compound4837
PDB IDPZE
ChEBI ID28568
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

Gene Name:
CYP2D6
Uniprot ID:
P10635